Qiagen NV
QIA: XETR (DEU)
Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
---|---|---|---|
€56.00 | Tcb | Wjqkjrrb |
Raising Qiagen's FVE on Better-Than-Expected COVID Demand in 2021; Headwinds Look Likely in 2022
No-moat Qiagen turned in fourth-quarter operating results that helped the firm significantly exceed our expectations for 2021. We are raising our fair value estimate by a high-single digit percentage basis on these strong recent results. However, we would note that COVID tailwinds appear to be turning into headwinds for Qiagen and look likely to produce a reduction in 2022 profits.